ARA-290 Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use ARA-290 report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
None of the studies we summarise for ARA-290 names a specific side effect. They report on safety only in general terms (below). Small and short studies often miss uncommon or delayed harms, so this is not evidence that ARA-290 is safe.
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Safety“No potential safety issues were identified.” | Frequency not stated | Human controlled trial | Molecular medicine 2015, PMID 25387363 |
| Safety assessments“No safety concerns were raised by clinical or laboratory assessments.” | Frequency not stated | Human RCTn = 22 | Molecular medicine 2012, PMID 23168581 |
| Serious adverse events and antibodies“No serious adverse events/reactions or anti-cibinetide antibodies were seen.” | Frequency not stated | Human uncontrolled trialn = 9 | Journal of clinical medicine 2020, PMID 32674280 |
What our search of PubMed and ClinicalTrials.gov found:
- Named side effects: none found. The ARA 290 and cibinetide trials (sarcoidosis, type 2 diabetes, diabetic macular edema, healthy volunteers) report no safety concerns or no serious adverse events without naming any specific adverse event in their abstracts.
What users report
Side effects people describe from their own use of ARA-290, quoted from 22 Reddit threads we read in r/PeptideGuide, r/Peptides and r/Retatrutide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Joint or muscle aches | 1 | “Days 1 and 2 I noticed lots of random aches and pains” r/Peptides, Mar 2026 |
| Injection-site welts | 1 | “i just started getting these welts” r/Peptides, Jun 2026Also taking other compounds |
| Injection-site burning | 1 | “PBS burns like a mf” r/Peptides, Sep 2026 |
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How ARA-290 interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
What the human trials reported about safety
In the sarcoidosis pilot of ARA 290 given into a vein, clinical and laboratory assessments raised no safety concerns.[2]
In the type 2 diabetes trial of daily subcutaneous ARA 290, no potential safety issues were identified.[1]
In the diabetic macular edema trial of cibinetide, no serious adverse events or reactions occurred and no antibodies to cibinetide were found; the trial enrolled only nine people.[3]
Why those findings are limited
The macular edema trial recruited nine patients and eight completed it, a sample too small to detect rare side effects.[3]
The reason the erythropoietin-derived design exists is that erythropoietin itself carries serious side effects that limit its clinical use.[1]
Common questions
What are the side effects of ARA 290?
The cached trials list no safety concerns, but they were small, short trials, so this is not a complete side-effect profile.[2]
What side effects do people who use ARA-290 report?
In the 22 Reddit threads we read (11 Oct 2026), people most often described joint or muscle aches (1 person), injection-site welts (1 person), injection-site burning (1 person). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is ARA-290 safe?
Its safety has not been established by an FDA review. ARA-290 is not FDA approved for any use. Research-chemical products are not checked for purity or dose.
Do ARA 290 trials report side effects?
The only safety statements here come from the three published trials; no user reports are used.[1]
More on ARA-290
Sources
- 1ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.Molecular medicine (Cambridge, Mass.) · 2015PMID 25387363Accessed 2 Oct 2026
- 2Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.Molecular medicine (Cambridge, Mass.) · 2012PMID 23168581Accessed 2 Oct 2026
- 3A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.Journal of clinical medicine · 2020PMID 32674280Accessed 2 Oct 2026
- 4Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 5Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 6Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
Found an error? Report a correction.